Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 14293 | 713 | 48.5 | 85% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1638 | 6431 | TRAMADOL//BREAKTHROUGH PAIN//MORPHINE 6 GLUCURONIDE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | OPRM1 | Author keyword | 36 | 50% | 7% | 52 |
| 2 | A118G | Author keyword | 20 | 66% | 3% | 19 |
| 3 | OPRM1 GENE | Author keyword | 17 | 100% | 1% | 8 |
| 4 | MU OPIOID RECEPTOR GENE | Author keyword | 11 | 69% | 1% | 9 |
| 5 | A118G POLYMORPHISM | Author keyword | 9 | 83% | 1% | 5 |
| 6 | OPRM1 A118G | Author keyword | 6 | 80% | 1% | 4 |
| 7 | ORAL HLTH CLIN SCI DENT ANESTHESIOL | Address | 4 | 75% | 0% | 3 |
| 8 | MOL EPIDEMIOL PAIN PROGRAM | Address | 3 | 50% | 1% | 5 |
| 9 | DELTA OPIOID RECEPTOR GENE | Author keyword | 3 | 100% | 0% | 3 |
| 10 | A118G SNP | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | OPRM1 | 36 | 50% | 7% | 52 | Search OPRM1 | Search OPRM1 |
| 2 | A118G | 20 | 66% | 3% | 19 | Search A118G | Search A118G |
| 3 | OPRM1 GENE | 17 | 100% | 1% | 8 | Search OPRM1+GENE | Search OPRM1+GENE |
| 4 | MU OPIOID RECEPTOR GENE | 11 | 69% | 1% | 9 | Search MU+OPIOID+RECEPTOR+GENE | Search MU+OPIOID+RECEPTOR+GENE |
| 5 | A118G POLYMORPHISM | 9 | 83% | 1% | 5 | Search A118G+POLYMORPHISM | Search A118G+POLYMORPHISM |
| 6 | OPRM1 A118G | 6 | 80% | 1% | 4 | Search OPRM1+A118G | Search OPRM1+A118G |
| 7 | DELTA OPIOID RECEPTOR GENE | 3 | 100% | 0% | 3 | Search DELTA+OPIOID+RECEPTOR+GENE | Search DELTA+OPIOID+RECEPTOR+GENE |
| 8 | A118G SNP | 2 | 67% | 0% | 2 | Search A118G+SNP | Search A118G+SNP |
| 9 | PHYSIOGENETICS | 2 | 67% | 0% | 2 | Search PHYSIOGENETICS | Search PHYSIOGENETICS |
| 10 | ALGESIOMETRY | 2 | 50% | 0% | 3 | Search ALGESIOMETRY | Search ALGESIOMETRY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | A118G POLYMORPHISM | 65 | 71% | 7% | 52 |
| 2 | A118G | 49 | 69% | 6% | 41 |
| 3 | OPRM1 | 33 | 52% | 6% | 45 |
| 4 | MORPHINE CONSUMPTION | 28 | 36% | 9% | 64 |
| 5 | POSTOPERATIVE TRAMADOL ANALGESIA | 21 | 85% | 2% | 11 |
| 6 | MORPHINE REQUIREMENTS | 17 | 43% | 4% | 30 |
| 7 | OPIOID RECEPTOR GENE | 13 | 22% | 7% | 53 |
| 8 | SUBSTANCE DEPENDENCE | 11 | 22% | 7% | 47 |
| 9 | BREAST FED NEONATE | 11 | 48% | 2% | 16 |
| 10 | GENE OPRM1 | 9 | 41% | 3% | 18 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human mu-opioid receptor (OPRM1) | 2015 | 4 | 104 | 36% |
| OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis | 2013 | 12 | 36 | 75% |
| OPRM1 SNP (A118G): Involvement in disease development, treatment response, and animal models | 2010 | 48 | 123 | 58% |
| mu-opioid receptor gene variant OPRM1 118 A > G: a summary of its molecular and clinical consequences for pain | 2013 | 7 | 66 | 83% |
| Pharmacogenetics of OPRM1 | 2014 | 4 | 107 | 64% |
| Genetic basis of pain variability: recent advances | 2012 | 37 | 110 | 37% |
| Is targeted opioid therapy within sight? | 2012 | 11 | 38 | 84% |
| Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians | 2012 | 13 | 36 | 72% |
| Pain genetics: past, present and future | 2012 | 57 | 121 | 22% |
| Pain and genetics | 2012 | 10 | 35 | 71% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ORAL HLTH CLIN SCI DENT ANESTHESIOL | 4 | 75% | 0.4% | 3 |
| 2 | MOL EPIDEMIOL PAIN PROGRAM | 3 | 50% | 0.7% | 5 |
| 3 | ANESTHESIOL ACUTE MED | 2 | 67% | 0.3% | 2 |
| 4 | SECT ANESTHESIOL USCITAT | 2 | 67% | 0.3% | 2 |
| 5 | POPULAT HLTH PROMOT SCI | 2 | 43% | 0.4% | 3 |
| 6 | ADDICT SUBST PROJECT | 1 | 25% | 0.7% | 5 |
| 7 | ABERDEEN PAIN ABORAT PRIMARY CARE | 1 | 100% | 0.3% | 2 |
| 8 | ANESTHESIA INTENS CARE PAIN THER Y ZAFES | 1 | 100% | 0.3% | 2 |
| 9 | CLIN PAIN SECT | 1 | 50% | 0.3% | 2 |
| 10 | PAIN THER Y SERV | 1 | 27% | 0.6% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000142594 | MORPHINE 6 GLUCURONIDE//MORPHINE 3 GLUCURONIDE//MORPHINE GLUCURONIDES |
| 2 | 0.0000109919 | METHADONE//EDDP//2 ETHYLIDENE 1 5 DIMETHYL 3 3 DIPHENYLPYRROLIDINE |
| 3 | 0.0000092347 | GABRA2//GABRG1//NEUROBEHAVIOR DISINHIBITION |
| 4 | 0.0000091965 | ACAMPROSATE//NALTREXONE//NALMEFENE |
| 5 | 0.0000091825 | CYP2D6//DEBRISOQUINE//CYP2C19 |
| 6 | 0.0000085844 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
| 7 | 0.0000081523 | MU OPIOID RECEPTOR//OPIOID RECEPTOR//MOR 1 |
| 8 | 0.0000079346 | BREAKTHROUGH PAIN//OPIOID ROTATION//CANCER PAIN |
| 9 | 0.0000078446 | NEUROENDOCRINE INFLUENCES PAIN//ADULT GONADECTOMY//ANTI ANALGESIA |
| 10 | 0.0000077452 | CATECHOL O METHYLTRANSFERASE//COMT//TOLCAPONE |